Keryx Biopharma Stock Price (NASDAQ:KERX)

Add to My Stocks
$7.06 $0.37 (4.98%) KERX stock closing price Jul 27, 2017 (Closing)
Prev Close* : $7.43
Market Cap:
$805.91M
Day Low: $6.83
52 Week Low: $4.03
Open: $7.5
Volume: 3085685
Day High: $7.51
52 Week High: $8.38
Dividend:
N/A

Latest Stock Market News

Latest Articles

Keryx Biopharma News - From Partners

KERX Stockcharts

View KERX PE ratio, PS ratio stocks charts and compare with peers.
KERX Chart
Note: Compare Keryx Biopharma stock price history with the index and industry peers.

Keryx Biopharma Valuation

PS ratio (
price to sales ratio
)
20.44
PB ratio (
price to book ratio
)
37.64

Keryx Biopharma Financial Ratios

Asset Turnover
0.35
Receivables Turnover
8.62

KERX Industry Peers

Company Price Change (%)
Aduro Biotech (ADRO)13.250.55 (3.99%)
Biohaven Pharm (BHVN)26.120.11 (0.42%)
Ardelyx (ARDX)5.450.15 (2.68%)
Akebia Therapeutics (AKBA)13.290.61 (4.39%)
Fibrogen (FGEN)33.71.8 (5.07%)
Affymax (AFFY)0.050 (0%)
Japan Tob Inc (JAPAY)16.950.08 (0.47%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Anika Therapeutics (ANIK)51.73.71 (7.73%)
Clovis Oncology (CLVS)92.254.82 (5.51%)
Compugen (CGEN)4.050.15 (3.85%)
AVEO Pharmaceuticals (AVEO)2.530.08 (3.27%)
Alexion Pharma (ALXN)133.922.85 (2.17%)
Puma Biotech (PBYI)96.651.35 (1.42%)
Cambrex (CBM)59.650.65 (1.1%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017
CompanyPriceChange (%)
Agenus (AGEN)4.480.78 (14.83%)
Dynavax Technologies (DVAX)9.251.15 (11.06%)
Uniquire (QURE)7.950.64 (7.45%)
OncoMed Pharma (OMED)3.320.26 (7.26%)
Inovio Pharma (INO)5.510.43 (7.24%)
Five Prime Therapeutics (FPRX)28.542.19 (7.13%)
Arbutus Biopharma (ABUS)3.50.25 (6.67%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 27, 2017

Keryx Biopharmaceuticals Stock News - Partner Headlines

Keryx Biopharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues31.98M13.68M10.82M7M-
Net Income-161.09M-123.14M-111.51M-46.73M-22.72M
Total Operating Expense114.05M118.1M121.55M54.07M27.07M
view Keryx Biopharmaceuticals income statement
balance sheet20162015201420132012
Total Assets141.42M258.68M103.62M60.76M18.56M
Total Liabilities149.72M171.75M30.14M15.36M8.07M
Shareholders Equity-8.29M86.93M73.48M45.4M10.49M
view Keryx Biopharmaceuticals balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-7.94M-35.57M2.55M6.4M-1.6M
Net Cash From (Used By) Operating Activities-86.6M-127.45M-81M-34.31M-24.76M
Increase (Decrease) In Prop Plant And Equipment-2.07M-2.77M-1.48M-0.34M-0.02M
view Keryx Biopharmaceuticals cashflow statement

Keryx Biopharma Stock Message Board

Keryx Biopharma stock price ended the last trading day at 7.43. Keryx Biopharma market capitalization is 808.08M and it represents the total market value of KERX stock. Keryx Biopharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Keryx Biopharma stock price and Keryx Biopharma share price mean the same thing. 842648 KERX shares were traded yesterday, and Keryx Biopharma stock chart shows that the KERX stock quote hit a day high of 7.56 and day low of 7.37. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of KERX, view Keryx Biopharma stock price history.